EGFR Exon 20 Insertion (A763_Y764insFQEA) Mutant NSCLC Is Not Identified by Roche Cobas Version 2 Tissue Testing but Has Durable Intracranial and Extracranial Response to Osimertinib.

Coleman, Niamh; Woolf, David; Welsh, Liam; McDonald, Fiona; MacMahon, Suzanne; Yousaf, Nadia; Popat, Sanjay

Coleman, Niamh; Woolf, David; Welsh, Liam; McDonald, Fiona; MacMahon, Suzanne; Yousaf, Nadia; Popat, Sanjay.

Afiliación

Coleman N; Lung Unit, The Royal Marsden Hospital, Chelsea, London, United Kingdom; Institute of Cancer Research, Sutton, London, United Kingdom.
Woolf D; The Christie National Health Service Foundation Trust, Wilmslow Road, Withington, Manchester.
Welsh L; Neuro-oncology Unit, The Royal Marsden Hospital, Chelsea, London, United Kingdom.
McDonald F; Lung Unit, The Royal Marsden Hospital, Chelsea, London, United Kingdom.
MacMahon S; Molecular Diagnostics, The Royal Marsden Hospital, Downs Road, Sutton, United Kingdom.
Yousaf N; Lung Unit, The Royal Marsden Hospital, Chelsea, London, United Kingdom.
Popat S; Lung Unit, The Royal Marsden Hospital, Chelsea, London, United Kingdom; Institute of Cancer Research, Sutton, London, United Kingdom. Electronic address: sanjay.popat@rmh.nhs.uk.

J Thorac Oncol ; 15(10): e162-e165, 2020 10.

Article en En | MEDLINE | ID: mdl-32981603

Asunto(s)

Neoplasias Pulmonares; Acrilamidas; Compuestos de Anilina; Receptores ErbB/genética; Exones/genética; Humanos; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/genética; Mutación

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google